These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9853241)

  • 1. Positron emission tomography as a diagnostic tool in oncology.
    Schiepers C; Hoh CK
    Eur Radiol; 1998; 8(8):1481-94. PubMed ID: 9853241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET in oncology: will it replace the other modalities?
    Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
    Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT: will it change the way that we use CT in cancer imaging?
    Hicks RJ; Ware RE; Lau EW
    Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Present status of PET images: clinical FDG PET in oncology].
    Inoue T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Nov; 59(13):737-44. PubMed ID: 10614103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of hybrid cameras in oncology.
    Delbeke D; Sandler MP
    Semin Nucl Med; 2000 Oct; 30(4):268-80. PubMed ID: 11105928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of positron emission tomography-computed tomography in oncology.
    Kumar R; Halanaik D; Malhotra A
    Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of positron emission tomography in the staging of lung cancer.
    Schiepers C
    Lung Cancer; 1997 Jun; 17 Suppl 1():S29-35. PubMed ID: 9213301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography imaging in oncology.
    Delbeke D; Martin WH
    Radiol Clin North Am; 2001 Sep; 39(5):883-917. PubMed ID: 11587060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography in diagnosis and management of invasive breast cancer: current status and future perspectives.
    Wu D; Gambhir SS
    Clin Breast Cancer; 2003 Apr; 4 Suppl 1():S55-63. PubMed ID: 12756080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET imaging in oncology.
    Bar-Shalom R; Valdivia AY; Blaufox MD
    Semin Nucl Med; 2000 Jul; 30(3):150-85. PubMed ID: 10928381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.
    Reske SN; Kotzerke J
    Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
    Granov AM; Tiushin LA; Tlostanova MS; Kostenikov NA; Ryzhkova DV; Savello VE; Stanzhevskiĭ AA
    Vopr Onkol; 2003; 49(5):563-73. PubMed ID: 14682126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy.
    Kao CH; Tsai SC; Wang JJ; Ho YJ; Yen RF; Ho ST
    Cancer; 2001 Jul; 92(2):434-9. PubMed ID: 11466699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical usefulness of FDG-PET in oncology].
    Sasaki M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of diagnostic PET in treatment planning before tumor surgery].
    Haberkorn U
    Chirurg; 2001 Sep; 72(9):1010-9. PubMed ID: 11594269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
    Salem SS; Shahin MA
    Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.